Brief: Achieve Life Sciences Announces Patent Granted By Uspto For New Cytisinicline Formulation
21/12/2022 13:04
Achieve Life Sciences Inc ACHV.O :
* ACHIEVE LIFE SCIENCES ANNOUNCES PATENT GRANTED BY USPTO
FOR NEW
CYTISINICLINE FORMULATION
Source text for Eikon: ID:nGNX15Q4DN
Further company coverage: ACHV.O
Recent news on Achieve Life Sciences
See all newsAchieve Life Sciences Q3 net loss and loss per share beat estimates
Brief: Achieve Life Sciences Presents 52-Week Cytisinicline Results For Smoking And Vaping Cessation At Chest 2026
Brief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Achieve Life Sciences Appoints Kaitlyn Tuson As Senior Vice President, Marketing And Communications
Brief: Achieve Life Sciences - Enters ATM Sale Agreement With Jefferies For Up To $150 Million In Common Stock